We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Neutrophil‐Lymphocyte Ratio and Lactate Predict Mortality in Septic Patients

By LabMedica International staff writers
Posted on 23 Jul 2019
Sepsis is the primary cause of death from infection. More...
It is also one of the leading causes of intensive care unit (ICU) mortality, despite early administration of antibiotics and hemodynamic management.

Plasma biomarkers may have diagnostic, prognostic, and theranostic values, all of which are important factors influencing outcomes in patients with sepsis. White blood cell (WBC) enumeration has been identified as an important systemic inflammation marker. The neutrophil‐to‐lymphocyte ratio (NLR) is a rapid and simple parameter of systemic inflammation and stress.

Scientists at the Changai Hospital (Shanghai, China) and their colleagues conducted a prospective, observational study that included 63 nonsurgical and non-trauma adult patients with sepsis admitted to the Department of Critical Care Medicine from September 2016 to October 2018. Baseline characteristics of the patients including demographics (age and gender), comorbidities (cardiovascular disease, chronic lung disease, and diabetes, among others), and primary diagnosis were recorded. In addition, healthy subjects were assigned to a control group.

The team collected blood samples within 24 hours after diagnosis. Routine blood tests, blood gas analysis, and procalcitonin (PCT) concentrations were conducted in the hospital's central laboratory. Routine blood tests, including neutrophil count and lymphocyte count performed on a blood analyzer, XN9000, C-reactive protein (CRP) estimated by scattering nephelometry, and plasma PCT concentrations were measured using a time‐resolved amplified cryptate emission technology assay. Plasma lactate was evaluated on an ABL800 Flex.

The scientists reported that NLR and plasma lactate levels of the patients were significantly higher than those of control subjects: 19.44 (14.3‐34.53) versus 14.09 (8.17‐28.99), and 3.7 (3‐6.6) versus 2.72 (2.13‐4.3) ng/mL, respectively. There were no statistical differences in the concentrations of PCT and CRP between non-survivors and survivors. With an optimal cutoff of 14.08, the sensitivity and specificity of NLR for prediction of 28‐day mortality were 78.3% and 50%, respectively. The sensitivity and specificity of plasma lactate level to predict 28‐day mortality, at an optimal cutoff value of 2.99 mmol/L, were 82.6% and 55%, respectively.

The authors concluded that elevated NLR and lactate levels showed significant association with increased mortality in patients with sepsis. NLR and lactate may be important prognostic biomarkers to optimize treatment and manage patients. The study was published on July 2, 2019, in the Journal of Clinical Laboratory Analysis.

Related Links:
Changai Hospital


New
Gold Member
Hematology Analyzer
Medonic M32B
Portable Electronic Pipette
Mini 96
New
Urine Chemistry Control
Dropper Urine Chemistry Control
New
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The nanotechnology-based liquid biopsy test could identify cancer at its early stages (Photo courtesy of 123RF)

2-Hour Cancer Blood Test to Transform Tumor Detection

Glioblastoma and other aggressive cancers remain difficult to control largely because tumors can recur after treatment. Current diagnostic methods, such as invasive biopsies or expensive liquid biopsies,... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.